UPDATE: JMP Securities Reiterates On Hyperion Therapeutics Inc As Diabetes Program Is Discarded
September 09, 2014 at 09:00 AM EDT
In a report published Tuesday, JMP Securities analyst Liisa A. Bayko reiterated a Market Outperform rating on Hyperion Therapeutics Inc ...